pharmceuticals

CVS Health Corp (NYSE: CVS) popped up more than 1% higher on Tuesday, which put the stock into blue skies. The stock has run over 11% higher since reaching a low of $99.69 on Jan. 24. The low was caused by overall market weakness amid the SPDR S&P 500 ETF Trust (NYSE: SPY) pulling...

A lack of clarity and final decision in the U.S. Food and Drug Administration's (FDA) recent letter to Iterum Therapeutics PLC (NASDAQ: ITRM) failed to deter H.C. Wainwright & Co’s bullish sentiment on Iterum stock. The Iterum Analyst: H.C. Wainwright & Co. analyst...